Table I

Phenotype and Frequency of B lymphocytes in Lymphoid Tissues

TissuePhenotypeIgHELIgHEL hCD19+/+sHEL IgHELsHEL IgHEL hCD19+/+
Frequency (%) and number (No. × 10−6) of B cells*
bone  % IgMB220lo         14 ± 2         14 ± 2      13 ± 2        13 ± 2 
marrow  % IgM+B220lo         32 ± 4         49 ± 10      46 ± 2        53 ± 3 
  % IgM+B220hi         16 ± 3  8 ± 3§      12 ± 2         8 ± 1 
  % HSAlo B220hi         25 ± 3          9 ± 3      17 ± 5         5 ± 1§ 
blood  % B220+         43 ± 3          7 ± 2      22 ± 3         6 ± 2 
  # B220+     2.4 ± 0.5      0.3 ± 0.1  0.9 ± 0.2         0.2 ± 0.1 
spleen  % B220+         36 ± 6         28 ± 5      44 ± 4        17 ± 3 
  # B220+         24 ± 5         14 ± 3§      29 ± 5        15 ± 6§ 
peritoneum  % CD5+ B220lo     2.2 ± 0.3      1.3 ± 0.4  4.5 ± 1.1         1.9 ± 0.7 
  # CD5+ B220lo     0.05 ± 0.01     0.05 ± 0.02  0.10 ± 0.02    0.04 ± 0.02 
  % CD5 B220hi         38 ± 6      2.7 ± 0.7      14 ± 2   1.2 ± 0.4 
  # CD5 B220hi     1.0 ± 0.3  0.07 ± 0.03§  0.33 ± 0.03   0.02 ± 0.01 
             
Expression  Source of B cells  Levels relative to IgHEL mice (% ± SEM) 
IgM levels:  bone  B220lo  100         69 ± 12      41 ± 9        22 ± 8 
  marrow:  B220hi  100         63 ± 4  4.1 ± 0.5         4.3 ± 0.7 
  blood:  B220+  100         68 ± 15      19 ± 3        25 ± 4 
  spleen:  B220+  100         62 ± 4      16 ± 2         7 ± 1 
I-A levels:  blood:  IgM+  100        126 ± 5     169 ± 7       254 ± 33 
  spleen:  IgM+  100        259 ± 55§     184 ± 13       283 ± 30§ 
TissuePhenotypeIgHELIgHEL hCD19+/+sHEL IgHELsHEL IgHEL hCD19+/+
Frequency (%) and number (No. × 10−6) of B cells*
bone  % IgMB220lo         14 ± 2         14 ± 2      13 ± 2        13 ± 2 
marrow  % IgM+B220lo         32 ± 4         49 ± 10      46 ± 2        53 ± 3 
  % IgM+B220hi         16 ± 3  8 ± 3§      12 ± 2         8 ± 1 
  % HSAlo B220hi         25 ± 3          9 ± 3      17 ± 5         5 ± 1§ 
blood  % B220+         43 ± 3          7 ± 2      22 ± 3         6 ± 2 
  # B220+     2.4 ± 0.5      0.3 ± 0.1  0.9 ± 0.2         0.2 ± 0.1 
spleen  % B220+         36 ± 6         28 ± 5      44 ± 4        17 ± 3 
  # B220+         24 ± 5         14 ± 3§      29 ± 5        15 ± 6§ 
peritoneum  % CD5+ B220lo     2.2 ± 0.3      1.3 ± 0.4  4.5 ± 1.1         1.9 ± 0.7 
  # CD5+ B220lo     0.05 ± 0.01     0.05 ± 0.02  0.10 ± 0.02    0.04 ± 0.02 
  % CD5 B220hi         38 ± 6      2.7 ± 0.7      14 ± 2   1.2 ± 0.4 
  # CD5 B220hi     1.0 ± 0.3  0.07 ± 0.03§  0.33 ± 0.03   0.02 ± 0.01 
             
Expression  Source of B cells  Levels relative to IgHEL mice (% ± SEM) 
IgM levels:  bone  B220lo  100         69 ± 12      41 ± 9        22 ± 8 
  marrow:  B220hi  100         63 ± 4  4.1 ± 0.5         4.3 ± 0.7 
  blood:  B220+  100         68 ± 15      19 ± 3        25 ± 4 
  spleen:  B220+  100         62 ± 4      16 ± 2         7 ± 1 
I-A levels:  blood:  IgM+  100        126 ± 5     169 ± 7       254 ± 33 
  spleen:  IgM+  100        259 ± 55§     184 ± 13       283 ± 30§ 
*

 Cumulative mean (± SEM) frequencies of different cell populations from at least five 2-mo-old mice of each genotype. Flow cytometry gates similar to those shown in Fig. 3 were used to determine the frequency of each cell type within the lymphocyte population. B cell numbers for blood indicate the number of cells/ml. B cell numbers from spleen and peritoneum were determined based on the total number of lymphocytes recovered.  

 Relative cell surface antigen densities were determined by comparing the channel numbers of mean linear fluorescence intensity between IgHEL B cells and B cells fom other mice. Values represent the mean expression levels obtained from at least three sets of mice of each genotype. All samples in each set of mice were stained in parallel and analyzed sequentially by flow cytometry with identical instrument settings.  

§

 Differences between mice not expressing hCD19 and those expressing hCD19 were significant, P <0.05.  

P <0.01.  

Close Modal

or Create an Account

Close Modal
Close Modal